STAT1 and systemic lupus erythematosus: Finally, we asked whether crippling JAK activity by using sub-saturating doses of JAK inhibitors could differentially affect STAT1 and STAT3 activation by HypIL-6 and therefore rescue the altered cytokine responses found in SLE patients.